VTR
Ventas, Inc.78.25
-0.46-0.58%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
36.76BP/E (TTM)
147.64Basic EPS (TTM)
0.53Dividend Yield
0.02%Recent Filings
8-K
8-K
Ventas boosts Q3 earnings, guidance
Ventas reported robust Q3 2025 results, with Normalized FFO per share climbing 10% to $0.88, fueled by 16% same-store cash NOI growth in its senior housing operating portfolio amid strong demand and 340 basis points higher U.S. occupancy year-over-year. The company closed $2.2 billion in senior housing acquisitions year-to-date, now comprising half its business, while raising $2.1 billion via equity forwards. It raised full-year senior housing investment guidance to $2.5 billion and Normalized FFO to $3.45-$3.48 per share. Net debt-to-EBITDA improved to 5.3x, yet higher interest costs loom.
10-Q
Q2 FY2025 results
Ventas posted solid Q2 momentum, with total revenues climbing 18.3% year-over-year to $1.42B, fueled by robust SHOP growth as resident fees and services surged 26.3% y/y to $1.03B amid higher occupancy and pricing. NOI jumped 14.3% y/y to $588.1M, with SHOP leading at 33.7% y/y growth to $286.4M, while OM&R and NNN held steady. Diluted EPS attributable to common stockholders rose to $0.15 from $0.05 y/y, reconciling cleanly with 459M weighted shares; operating cash flow for the half-year hit $796.5M, yielding free cash flow of $536.5M after $260M capex (derived). Debt eased to $13.1B from $13.5B year-end, with $614M cash bolstering $4.7B liquidity. Acquisitions added 23 SHOP communities for $961.5M, but impairments ticked up to $34.9M. Tenant concentration lingers as a key watchpoint.
8-K
Ventas boosts Q2 earnings, guidance
Ventas reported robust Q2 2025 results, with Normalized FFO per share climbing 9% to $0.87, fueled by 13% year-over-year SHOP Same-Store Cash NOI growth amid surging senior housing demand. Year-to-date, the company closed $1.1 billion in senior housing investments, boosting its full-year target to $2 billion. Yet leverage eased to 5.6x Net Debt-to-Further Adjusted EBITDA. Guidance lifted Normalized FFO to $3.41-$3.46 per share.
8-K
Ventas expands stock sales cap
Ventas boosted its at-the-market sales agreement on June 13, 2025, raising the cap on common stock issuance to $2.25 billion, excluding prior sales. This amendment with major agents and forward purchasers enhances capital access under an existing S-3 registration. Yet dilution risks loom for shareholders. Forward-looking statements highlight market uncertainties.
IPO
Website
Employees
Sector
Industry
AHR
American Healthcare REIT, Inc.
47.62+0.42
CTRE
CareTrust REIT, Inc.
36.32-0.27
DOC
Healthpeak Properties, Inc.
16.36-0.30
HR
Healthcare Realty Trust Incorpo
17.02-0.21
LTC
LTC Properties, Inc.
34.41-0.57
NHI
National Health Investors, Inc.
76.77-1.26
STRW
Strawberry Fields REIT, Inc.
13.08-0.60
VICI
VICI Properties Inc.
28.31-0.29
VRE
Veris Residential, Inc.
14.61-0.22
WELL
Welltower Inc.
190.40-0.07